Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 201.15

-1.3%

Jan 23 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Abuckatatime who wrote (10108)	10/24/1997 9:53:00 PM
From: Henry Niman	Read Replies (1) of 32384

Greg, A few years ago LGND signed a 10 year Canadian rights deal with QLTIF to sell PHOTOFRIN for ANY indication. At the time it was approved for superficial bladder cancer. A year or so ago it was approved for esophgeal cancer. I believe it is alreadsy approved for lung cancer in Europe (France?) and its pending for that indication inthe US and Canada. LGND really did the deal to set the stage for Canadian clinical trials as well as a rapid launch of retinoids. It is my understaning that they have already begun sceening Cnadians for a type II diabetes trial with oral Targretin.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next